These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


375 related items for PubMed ID: 15254061

  • 1. Recommended guidelines for the treatment of cancer treatment-induced diarrhea.
    Benson AB, Ajani JA, Catalano RB, Engelking C, Kornblau SM, Martenson JA, McCallum R, Mitchell EP, O'Dorisio TM, Vokes EE, Wadler S.
    J Clin Oncol; 2004 Jul 15; 22(14):2918-26. PubMed ID: 15254061
    [Abstract] [Full Text] [Related]

  • 2. Chemotherapy induced diarrhea.
    Richardson G, Dobish R.
    J Oncol Pharm Pract; 2007 Dec 15; 13(4):181-98. PubMed ID: 18045778
    [Abstract] [Full Text] [Related]

  • 3. Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy- and radiotherapy-induced diarrhea.
    Muehlbauer PM, Thorpe D, Davis A, Drabot R, Rawlings BL, Kiker E.
    Clin J Oncol Nurs; 2009 Jun 15; 13(3):336-41. PubMed ID: 19502193
    [Abstract] [Full Text] [Related]

  • 4. Understanding and managing chemotherapy-induced diarrhea.
    Saltz LB.
    J Support Oncol; 2003 Jun 15; 1(1):35-46; discussion 38-41, 45-6. PubMed ID: 15352641
    [Abstract] [Full Text] [Related]

  • 5. Evaluation and management of treatment-related diarrhea in patients with advanced cancer: a review.
    Cherny NI.
    J Pain Symptom Manage; 2008 Oct 15; 36(4):413-23. PubMed ID: 18411014
    [Abstract] [Full Text] [Related]

  • 6. Updated clinical practice guidelines for the prevention and treatment of mucositis.
    Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology.
    Cancer; 2007 Mar 01; 109(5):820-31. PubMed ID: 17236223
    [Abstract] [Full Text] [Related]

  • 7. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, Leifer B, Mills C, Minkoff N, Orland B, Reichman WE, Salloway S.
    Am J Geriatr Pharmacother; 2006 Mar 01; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [Abstract] [Full Text] [Related]

  • 8. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
    Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I.
    J Urol; 2007 Feb 01; 177(2):540-5. PubMed ID: 17222629
    [Abstract] [Full Text] [Related]

  • 9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Feb 01; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 10. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH.
    Eur J Cancer Care (Engl); 2004 Sep 01; 13(4):380-3. PubMed ID: 15305907
    [Abstract] [Full Text] [Related]

  • 11. [Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)].
    Conroy T, Gory-Delabaere G, Adenis A, Bosquet L, Bouché O, Louvet C, Mitry E, Bécouarn Y, Bosset JF, Ducreux M, Etienne PL, Merrouche Y, Monges G, Rougier P, Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC), Fédération Hospitalière de France (FHF), Fédération Nationale de Cancérologie des Centres Hospitaliers Régionaux et Universitaires (FNCCHRU), Fédération Française de Cancérologie des Centres Hospitaliers Généraux (FFCCHG), Centres Régionaux de Lutte Contre le Cancer (CRLCC), Fédération Française de Cancérologie Digestive (FFCD), Société Nationale Française de Gastro-Entérologie (SNFGE), Groupe coopérateur multidisciplinaire en oncologie (Gercor).
    Bull Cancer; 2004 Oct 01; 91(10):759-68. PubMed ID: 15556876
    [Abstract] [Full Text] [Related]

  • 12. Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
    Wadler S, Benson AB, Engelking C, Catalano R, Field M, Kornblau SM, Mitchell E, Rubin J, Trotta P, Vokes E.
    J Clin Oncol; 1998 Sep 01; 16(9):3169-78. PubMed ID: 9738589
    [Abstract] [Full Text] [Related]

  • 13. Management of diarrhea in clinical practice: strategies for primary care physicians.
    Schiller LR.
    Rev Gastroenterol Disord; 2007 Sep 01; 7 Suppl 3():S27-38. PubMed ID: 18192963
    [Abstract] [Full Text] [Related]

  • 14. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
    International Liaison Committee on Resuscitation.
    Pediatrics; 2006 May 01; 117(5):e955-77. PubMed ID: 16618790
    [Abstract] [Full Text] [Related]

  • 15. Guidance on the management of diarrhoea during cancer chemotherapy.
    Andreyev J, Ross P, Donnellan C, Lennan E, Leonard P, Waters C, Wedlake L, Bridgewater J, Glynne-Jones R, Allum W, Chau I, Wilson R, Ferry D.
    Lancet Oncol; 2014 Sep 01; 15(10):e447-60. PubMed ID: 25186048
    [Abstract] [Full Text] [Related]

  • 16. Management of diarrhea induced by tumors or cancer therapy.
    Cascinu S.
    Curr Opin Oncol; 1995 Jul 01; 7(4):325-9. PubMed ID: 7578380
    [Abstract] [Full Text] [Related]

  • 17. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E, Karaoglu A.
    Oncology; 2006 Jul 01; 71(5-6):354-60. PubMed ID: 17873499
    [Abstract] [Full Text] [Related]

  • 18. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease.
    Sautter-Bihl ML, Souchon R, Budach W, Sedlmayer F, Feyer P, Harms W, Haase W, Dunst J, Wenz F, Sauer R.
    Strahlenther Onkol; 2008 Jul 01; 184(7):347-53. PubMed ID: 19016032
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec 01; 14(80):230-3. PubMed ID: 16400749
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.
    Jpn J Clin Oncol; 2007 Sep 01; 37(9):686-91. PubMed ID: 17720736
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.